Proposed Class Action Settlement May Cost Acella $46.5M

By Cassie M. Chew · February 5, 2024, 7:47 PM EST

A proposed agreement to end a class action over thyroid medication, after a U.S. Food and Drug Administration inspection found products with an active ingredient above and below label specifications, may...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Faulkner v. Acella Pharmaceuticals, LLC

Case Number

2:22-cv-00092

Court

Georgia Northern

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

May 12, 2022